Login / Signup

Understanding the interplay between chronic lymphocytic leukemia and type 2 diabetes.

Noomi VainerViktor Rotbain CurovicCarsten Utoft NiemannSusan L SlagerEmelie Curovic Rotbain
Published in: Expert review of hematology (2024)
The increased mortality observed in persons with CLL who have co-existing T2D is partially ascribed to infections, prompting physicians managing individuals with both conditions to consider closer monitoring during instances of infection and individualized prophylaxis. People with CLL and T2D should be managed for CLL in accordance with the international working group on CLL criteria, and we recommend that physicians exercise particular care not to delay treatment for these individuals. Multidisciplinary approaches with involvement of several specialties may be required for optimal supportive care of co-occurring T2D and CLL.
Keyphrases